Summary
The receptor systems through which serotonin (5-HT), histamine, angiotensin II and endothelin increase the force of contraction were studied in isolated right atria from patients without apparent heart failure.
All agonists increased the atrial force of contraction in a concentration-dependent manner; maximal effects, however, were significantly less than those evoked by isoprenaline or Ca2+. 5-HT and histamine, but not angiotensin II and endothelin, activated adenylate cyclase, whereas endothelin and angiotensin II stimulated inositol phosphate generation. Experiments with subtype-selective antagonists revealed that histamine effects were mediated by H2-receptors (sensitive to ranitidine), 5-HT-effects by 5-HT4-receptors (sensitive to SDZ 205-557) and angiotensin II effects by AT1-receptors (sensitive to losartan).
We conclude that in human right atria the force of contraction can be increased by cyclic AMP-dependent (histamine, 5-HT) and -independent (angiotensin II, endothelin) pathways. Compared to β-adrenoceptors, however, all other receptor systems increase the force of contraction only submaximally indicating that the β-adrenoceptor pathway is the most important physiological mechanism to regulate force of contraction and/or heart rate in the human heart.
Similar content being viewed by others
References
Abdellatif MM, Neubauer CF, Lederer WJ, Rogers TB (1991) Angiotensin-induced desensitization of the phosphoinositide pathway in cardiac cells occurs at the level of the receptor. Circ Res 69:800–809
Arunlakshana O, Schild HO (1959) Some quantitative uses of antagonist. Br J Pharmacol 14:48–58
Baumann G, Mercader D, Busch U, Felix SB, Loher U, Ludwig L, Sebening H, Heidecke CD, Hagl S, Sebening F, Blömer H (1983) Effects of the H2-receptor agonist impromidine in human myocardium from patients with heart failure due to mitral and aortic valve disease. J Cardiovasc Pharmacol 5:618–625
Böhm M, Diet F, Feiler G, Kemkes B, Erdmann E (1988) α-Adrenoceptors and α-adrenoceptor-mediated positive inotropic effects in failing human myocardium. J Cardiovasc Pharmacol 12:357–364
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Bristow MR, Cubicciotti R, Ginsburg R, Stinson EB, Johnson C (1982) Histamine-mediated adenylate cyclase stimulation in human myocardium. Mol Pharmacol 21:671–679
Bristow MR, Minobe W, Rasmussen R, Hershberger RE, Hoffman BB (1988) Alpha-1 adrenergic receptors in the nonfailing and failing human heart. J Pharmacol Exp Ther 247:1039–1045
Bristow MR, Hershberger RE, Port JD, Gilbert EM, Sandoval A, Rasmussen R, Cates AE, Feldman AM (1990) β-Adrenergic pathways in nonfailing and failing human ventricular myocardium. Circulation 82 [Suppl I]:I-12-I-25
Brodde O-E (1991) β1- and β2-Adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev 43:203–242
Brown L, Deighton NM, Bals S, Söhlmann W, Zerkowski H-R, Michel MC, Brodde O-E (1992) Spare receptors for β-adrenoceptor-mediated positive inotropic effects of catecholamines in the human heart. J Cardiovasc Pharmacol 19:222–232
Buchheit K-H, Gamse R, Pfannkuche H-J (1991) SDZ 205–557, a selective antagonist at 5-HT4 receptors in the isolated guinea pig ileum. Eur J Pharmacol 200:373–374
Buchheit K-H, Gamse R, Pfannkuche H-J (1992) SDZ 205–557, a selective, surmountable antagonist for 5-HT4 receptors in the isolated guinea pig ileum. Naunyn-Schmiedeberg's Arch Pharmacol 345:387–393
Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol 22:3099–3108
Chin AT, McCall DE, Price WA, Wong PC, Carini DJ, Duncia JV, Johnson AL, Wexler RR, Yoo SE, Timmermans PBMWM (1990) Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther 252:711–718
Deighton NM, Motomura S, Bals S, Zerkowski H-R, Brodde O-E (1992) Characterization of the beta-adrenoceptor subtype(s) mediating the positive inotropic effects of epinine, dopamine, dobutamine, denopamine and xamoterol in isolated human right atrium. J Pharmacol Exp Ther 262:532–538
Dooley DJ, Bittiger H, Reymann NC (1986) CGP 20712 A: a useful tool for quantitating β1- and β2-adrenoceptors. Eur J Pharmacol 130:137–139
Dumuis A, Bouhelal R, Sebben M, Cory R, Bockaert J (1988) A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. Mol Pharmacol 34:880–887
Dumuis A, Sebben M, Bockaert J (1989) The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate-cyclase in neurons. Naunyn-Schmiedeberg's Arch Pharmacol 340:403–410
Hershberger RE, Anderson FL, Bristow MR (1989) Vasoactive intestinal peptide receptor in failing human ventricular myocardium exhibits increased affinity and decreased density. Circ Res 65:283–294
Ishihata A, Endoh M (1992) Involvement of phosphoinositide metabolism in the positive inotropic effect of angiotensin II. J Mol Cell Cardiol 24 (Suppl I):S84 (abstract)
Jones CR, Molenaar P, Summers RJ (1989) New views of human cardiac β-adrenoceptors. J Mol Cell Cardiol 21:519–535
Kaumann AJ, Sanders L, Brown AM, Murray KJ, Brown MJ (1990) A 5-hydroxytryptamine receptor in human atrium. Br J Pharmacol 100:879–885
Kaumann AJ, Sanders L, Brown AM, Murray KJ, Brown MJ (1991) A 5-HT4-like receptor in human right atrium. Naunyn-Schmiedeberg's Arch Pharmacol 344:150–159
Kohl C, Schmitz W, Scholz H, Scholz J, Toth M, Döring V, Kalmar P (1989) Evidence for alpha1-adrenoceptor-mediated increase of inositol trisphosphate in the human heart. J Cardiovasc Pharmacol 13:324–327
Leurs R, Timmerman H (1991) Histaminergic receptors. In: Doods HN, van Meel JCA (eds) Ellis Horwood, New York London, pp 47–53
McDevitt DG (1989) In vivo studies on the function of cardiac β-adrenoceptors in man. Eur Heart J 10 [Suppl B]:22–28
Motomura S, Zerkowski H-R, Daul A, Brodde O-E (1990) On the physiologic role of beta-2 adrenoceptors in the human heart: in vitro and in vivo studies. Am Heart J 119:608–619
Näbauer M, Böhm M, Brown L, Diet F, Eichhorn M, Kemkes B, Pieske B, Erdmann E (1988) Positive inotropic effects in isolated ventricular myocardium from non-failing and terminally failing human hearts. Eur J Clin Invest 18:600–606
Quadid H, Seguin J, Dumuis A, Bockaert J, Nargeot J (1992) Serotonin increases calcium current in human atrial myocytes via the newly described 5-hydroxytryptamine4 receptors. Mol Pharmacol 41:346–351
Richardson BP, Engel G, Donatsch P, Stadler PA (1985) Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature (Lond) 316:126–131
Salomon Y, Londos C, Rodbell M (1974) A highly sensitive adenylate cyclase assay. Anal Biochem 58:541–548
Sanders L, Kaumann AJ (1992) A 5-HT4-like receptor in human left atrium. Naunyn-Schmiedeberg's Arch Pharmacol 345:382–386
Schomisch Moravec C, Reynolds EE, Stewart RW, Bond M (1989) Endothelin is a positive inotropic agent in human and rat heart in vitro. Biochem Biophys Res Commun 159:14–18
Schomisch Moravec C, Schluchter MD, Paranandi L, Czerska B, Stewart RW, Rosenkranz E, Bond M (1990) Inotropic effects of angiotensin II on human cardiac muscle in vitro. Circulation 82:1973–1984
Steinfath M, Danielsen W, Von der Leyen H, Mende U, Meyer W, Neumann J, Nose M, Reich T, Schmitz W, Scholz H, Starbatty J, Stein B, Döring V, Kalmar P, Haverich A (1992) Reduced α1- and β2-adrenoceptor-mediated positive inotropic effects in human endstage heart failure. Br J Pharmacol 105:463–469
Takanashi M, Endoh M (1991) Characterization of positive inotropic effects of endothelin on mammalian ventricular myocardium. Am J Physiol 261:H611-H619
Timmermans PBMWM, Wong PC, Vhiu AT, Herblin WF (1991) Nonpeptide angiotensin II receptor antagonists. Trends Pharmacol Sci 12:55–62
Van Rossum JM (1963) Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and evaluation of drug parameters. Arch Int Pharmacodyn Ther 143:299–330
Author information
Authors and Affiliations
Additional information
Correspondence to O. E. Brodde at the above address
Rights and permissions
About this article
Cite this article
Zerkowski, HR., Broede, A., Kunde, K. et al. Comparison of the positive inotropic effects of serotonin, histamine, angiotensin II, endothelin and isoprenaline in the isolated human right atrium. Naunyn-Schmiedeberg's Arch Pharmacol 347, 347–352 (1993). https://doi.org/10.1007/BF00165383
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00165383